Abstract
Green chemistry of nanomaterials from synthesis to diverse biomedical applications is a discussion of town in the current scientific scenario. In this work, Ocimum basilicum leaves extract was utilized as the reducing agent in the synthesis of ZnO nanoparticles. Green synthesized ZnO NPs mediated via Ocimum basilicum extract were decorated on the reduced graphene oxide (RGO) sheet by the simple one-step method. The prepared green synthesized RGO-ZnO nanocomposites (NCs) were characterized via the X-ray diffractometer. The average crystallite size of ZnO was 25 nm which confirmed the wurtzite hexagonal structure of ZnO. The scanning Electron Microscopy technique confirmed the spherical morphology of particle size of 31 nm. Further, Fourier Transform Infrared Spectroscopy confirms the Zn-O bond stretching in the RGO-ZnO NCs. Antioxidant activity of the green synthesized Ocimum basilicum ZnO NPs and RGO-ZnO NCs were performed by DPPH scavenging activities and found the dose-dependent. RGO-ZnO effectively inhibited the α-amylase and α-glucosidase for in vitro antidiabetic activities. Moreover, RGO-ZnO NCs showed the antibacterial potential with increasing concentration against the gram-positive (Cocci) and gram-negative (E. coli) bacterial strains. In Photocatalytic activity, the ZnO NPs and RGO-ZnO NCs were utilized as the catalyst and degraded the Rh-B dye 91.4% and 96.7% under UV–visible light. Overall, RGO-ZnO NCs showed better results in antibacterial, antidiabetic activity as well as photocatalytic activity against the pure ZnO NPs. Hence, RGO-ZnO nanocomposites have demonstrated the opportunity to be an entrancing material for photocatalysis and biological studies.